COPENHAGEN (Reuters) -Shares in Novo Nordisk rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its ...

Novo Nordisk lost an intense bidding war against Pfizer for U.S. biotech firm Metsera. CNBC takes a look at what the options ...

Get the daily news here. Read the essential Danish news and topics of today - in English. Politiken Edition is your window to ...

Investing.com - U.S. stock futures rose sharply Monday after the Senate voted in favor of a bill aimed at ending the ...

Shares of Novo Nordisk increased after the company withdrew its bid for U.S. weight loss drug maker Metsera, allowing Pfizer to secure a $10 billion deal. This move grants Pfizer entry into the ...

Novo Nordisk saw a slight rise in shares after withdrawing its bid for U.S. weight loss drug company Metsera, losing out to Pfizer in a bidding war. Pfizer secured a $10 billion deal, marking a ...

Dow Jones futures gain 0.18% to trade above 47,150 during European hours ahead of the opening of the United States (US) ...